Gracell Biotechnologies Overview

Gracell Biotechnologies Operating Income

Operating Income for GRCL.

Quarterly Operating Income

$-121755000.00

↓ 28.29% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$-578825000.00

↓ 5.87% YoY

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin